Regulatory & Legal

A routine filing by hedge fund Balyasny Asset Management may have just put Avadel Pharmaceuticals in the M&A spotlight. Here's what the signal means.

Nordic American Tankers is riding a wave of record profits, but the industry's future hinges on volatile markets and the shadow of Venezuelan oil.

Amid a major corporate overhaul, Emergent BioSolutions secures a key FDA approval, signaling a new era for the firm and for U.S. biodefense strategy.

A novel drug for alcohol use disorder gets key scientific backing. It promises the benefits of psychedelics with fewer risks, shaking up a $35B market.

Fresh off its IPO, iOThree is pushing AI and certified digital tools. Can its innovation engine and Asian expansion overcome market headwinds?

A junior miner is fast-tracking gold and critical metals production in Québec by reviving a key mill. Is this a strategic supply chain win or just savvy promotion?

With over 123 million displaced, refugee camps are now de facto cities. Temporary water solutions are fueling disease, making the case for permanent fixes.

With a €1.5B capital raise backed by governments and strategic giants, Eutelsat is fueling its unique hybrid satellite network to compete in the new space race.

Colombia's energy giant Ecopetrol reshuffles key committees after high-profile resignations. Is this a strategic shift or a move to steady the ship?

A $277M secondary offering sees MIAX shareholders cash in, but the company itself isn't taking any money. Here’s what that says about its financial power.

Long Beach's new Black-Serving Institution status isn't just an equity win; it's a strategic investment in the diverse STEM talent America's defense sector needs.

Serina Therapeutics poaches a top chemist to expand its POZ platform, signaling a major push beyond Parkinson's into new, high-value drug markets.

Duff & Phelps's fund maintains its payout, but the real story is its bet on an AI-driven energy boom. We unpack the strategy and its risks.

Erie Indemnity boosts its dividend by 7.1%, but a deeper look reveals a unique and legally challenged fee structure driving its profitability.

Tenaya Therapeutics seeks fresh capital to advance its heart disease pipeline, but the offering's structure raises dilution questions for investors.

Dynex's routine dividend declaration reveals a complex strategy of risk management and capital allocation, offering a masterclass in navigating mREIT turbulence.

PG&E's new grid tech does more than keep lights on; it's a vital upgrade for healthcare resilience, wildfire prevention, and safety in a changing climate.

New journalism awards tackle AI's risks and Indigenous health gaps, revealing how media innovation aims to build a healthier, more equitable Canada.

A routine filing reveals a major strategic play. See how BridgeBio Oncology uses special equity grants to attract top minds in the fierce race for a cancer cure.

A 150-year-old agricultural giant is pivoting its strategy, using a sophisticated data model to link sustainability directly to its bottom line.